After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Roivant Sciences Ltd is $16.20B. A total of 6.32 million shares were traded on the day, compared to an average of 8.05M shares.
In the most recent transaction, Venker Eric sold 200,000 shares of ROIV for 21.92 per share on Jan 12 ’26. After the transaction, the President & Immunovant CEO now owns 1,654,597 company shares. In a previous transaction on Jan 12 ’26, Venker Eric bought 200,000 shares at 21.92 per share.
Among the insiders who sold shares, Sukhatme Mayukh disposed of 1,018,995 shares on Dec 31 ’25 at a per-share price of $21.71. This resulted in the President & CIO holding 20,267,429 shares of ROIV after the transaction. In another insider transaction, Sukhatme Mayukh sold 311,873 shares at $21.74 per share on Dec 29 ’25. Company shares held by the President & CIO now total 19,273,032.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ROIV has a high of $23.83 and a low of $8.73.
As of this writing, ROIV has an earnings estimate of -$0.31 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.23 per share and a lower estimate of -$0.45. The company reported an EPS of -$0.2 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ROIV’s latest balance sheet shows that the firm has $2.06B in Cash & Short Term Investments as of fiscal 2022. There were $283.89M in debt and $184.37M in liabilities at the time. Its Book Value Per Share was $6.32, while its Total Shareholder’s Equity was $2.06B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
